Tecan Group Ltd (TECN) - Medical Equipment - Deals and Alliances Profile
October 2018
49
About the Report
About the Report
Summary
Tecan Group Ltd (Tecan) is a provider of automated laboratory instruments and solutions for use in basic and translational research, clinical diagnostics, and drug discovery. The company develops, manufactures, and markets automated workflow solutions for laboratories and instrumentation suppliers. Its product portfolio encompasses liquid handling and robotics, reader and washer, microarray products, components, software, and consumables. Tecan's products find applications in agriculture, forensic solutions, analytical chemistry, cell biology, drug discovery, genomic solutions, protein science solutions, ELISA solutions and synthetic biology. The company has manufacturing facilities, and research and development facilities in Europe and North America. Tecan is headquartered in Mannedorf, Zurich, Switzerland.
Tecan Group Ltd (TECN)-Medical Equipment-Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.
GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.
Scope
- Financial Deals-Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year-Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type-Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region-Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector-Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals-Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company's (major public companies) key financial metrics and ratios.
- Business Description-A brief description of the company's operations.
- Key Employees-A list of the key executives of the company.
- Important Locations and Subsidiaries-A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors-A list of the key competitors of the company.
- Key Recent Developments-A brief on recent news about the company.
Reasons to buy
Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements
- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.
Understand the company's business segments' expansion / divestiture strategy
- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.
Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.
Equip yourself with detailed information about the company's operations to identify potential customers and suppliers.
- The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.
Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.
Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.
Note*: Some sections may be missing if data is unavailable for the company.
Products
Products
Tecan Group Ltd, Deal Analysis, Mergers, Acquisitions, Asset Purchases, Asset Divestitures, Company Divestitures, Equity Offerings, Capital Raising, Debt Offerings, IPOs, Initial Public Offering, Private Placement, Private Investment In Public Equities, Secondary Offerings, Follow-On Offerings, Debt Private Placement, Public Debt Placement, Partnerships, Joint Venture, Licensing Agreements, Co-Marketing Agreements, Upfront Payment, Milestone Payment, Phases, Clinical Trials, Private Equity, Venture Capital, PE,VC, Asset Finance, Project Finance, Tax Equity Financing, Bond Financing, Lease Financing, New Build Financing, Deal Analysis By Market/sector, Deal Analysis By Geography, Deal Analysis By Deal Types, Key Employees, Locations And Subsidiaries, Competitors, Recent News, Company Overview, Key Facts, Deals By Year, Deal Details, Recent Developments, Significant Developments.
Table of Contents
Table of Contents
Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Tecan Group Ltd, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Tecan Group Ltd, Medical Equipment Deals By Type, 2012 to YTD 2018 6
Tecan Group Ltd, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Tecan Group Ltd, Medical Equipment, Deals By Market, 2012 to YTD 2018 8
Tecan Group Ltd, Medical Equipment, Deals Summary, 2012 to YTD 2018 9
Tecan Group Ltd, Medical Equipment, Deal Details 10
Partnerships 10
Immuno-Biological Labs Enters Into Licensing Agreement With IBL International 10
IBL International And Leiden University Medical Centre Enter Into Licensing Agreement For Myasthenia Gravis Diagnostics 11
Radisens Enters Into Licensing Agreement With Tecan 12
DiaSorin Enters into Agreement with Tecan 13
Singulex Enters Into Co-Development Agreement With Tecan 14
ViroGates Enters Into Distribution Agreement With IBL International 15
Biohit Enters Into Distribution Agreement With IBL International For GastroPanel 16
IBL International Enters Into Distribution Agreement With Sanquin Blood Supply Foundation 17
Tecan Group Enters Into Co-Marketing Agreement With TAP Biosystem For RAFT System 18
Reinnervate Enters Into Co-Development Agreement With Tecan Group 19
University of Duisburg-Essen Enters Into Licensing Agreement With IBL International 20
Acquisition 21
Tecan Group Acquires NuGEN Technologies for USD54.5 Million 21
Tecan Acquires SPEware 22
Tecan Completes Acquisition of IBL International for USD39 Million 23
Tecan Group Ltd-Key Competitors 24
Tecan Group Ltd-Key Employees 25
Tecan Group Ltd-Locations And Subsidiaries 26
Head Office 26
Other Locations & Subsidiaries 26
Recent Developments 28
Financial Announcements 28
Aug 16, 2018: H1 2018: Tecan posts strong increase in sales, driven by growth in the Partnering Business 28
Aug 16, 2018: Tecan: Financial results for the first half of 2018 31
Aug 16, 2018: Tecan posts strong increase in sales, driven by growth in the Partnering Business 34
Aug 16, 2017: H1 2017: Tecan with significant increase in order entry and strong sales growth in the Life Sciences Business 37
Mar 15, 2017: Full year 2016: Another year of double-digit sales growth for Tecan 40
Corporate Communications 43
Oct 06, 2017: Tecan initiates succession process for the Board of Directors 43
Jun 02, 2017: Tecan appoints Erik Norstrom Head of Corporate Development 44
Jun 02, 2017: Tecan appoints Erik Norstrom Head of Corporate Development 45
Jan 10, 2017: Tecan appoints Klaus Lun Head of the Life Sciences Business division 46
Other Significant Developments 47
Jul 03, 2018: Tecan's Spark reader aiding research into rare skin disease 47
Jan 25, 2018: Tecan to launch Fluent Gx Automation Workstation for use in regulated laboratories 48
Appendix 49
Methodology 49
About GlobalData 49
Contact Us 49
Disclaimer 49
List of Figure
List of Figures
Tecan Group Ltd, Medical Equipment, Deals by Type, 2012 to YTD 2018 2
Tecan Group Ltd, Medical Equipment, Deals By Year, 2012 to YTD 2018 2
Tecan Group Ltd, Medical Equipment, Deals By Region, 2012 to YTD 2018 2
Tecan Group Ltd, Medical Equipment, Deals By Market, 2012 to YTD 2018 2
Tecan Group Ltd, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Tecan Group Ltd, Medical Equipment, Deals by Type, 2012 to YTD 2018 6
Tecan Group Ltd, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Tecan Group Ltd, Medical Equipment, Deals by Market, 2012 to YTD 2018 8
List of Table
List of Tables
Tecan Group Ltd, Medical Equipment, Key Facts, 2017 2
Tecan Group Ltd, Medical Equipment, Deals Summary, 2012 to YTD 2018 2
Tecan Group Ltd, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Tecan Group Ltd, Medical Equipment Deals By Type, 2012 to YTD 2018 6
Tecan Group Ltd, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Tecan Group Ltd, Deals By Market, 2012 to YTD 2018 8
Tecan Group Ltd, Medical Equipment, Deals Summary, 2012 to YTD 2018 9
Immuno-Biological Labs Enters Into Licensing Agreement With IBL International 10
IBL International And Leiden University Medical Centre Enter Into Licensing Agreement For Myasthenia Gravis Diagnostics 11
Radisens Enters Into Licensing Agreement With Tecan 12
DiaSorin Enters into Agreement with Tecan 13
Singulex Enters Into Co-Development Agreement With Tecan 14
ViroGates Enters Into Distribution Agreement With IBL International 15
Biohit Enters Into Distribution Agreement With IBL International For GastroPanel 16
IBL International Enters Into Distribution Agreement With Sanquin Blood Supply Foundation 17
Tecan Group Enters Into Co-Marketing Agreement With TAP Biosystem For RAFT System 18
Reinnervate Enters Into Co-Development Agreement With Tecan Group 19
University of Duisburg-Essen Enters Into Licensing Agreement With IBL International 20
Tecan Group Acquires NuGEN Technologies for USD54.5 Million 21
Tecan Acquires SPEware 22
Tecan Completes Acquisition of IBL International for USD39 Million 23
Tecan Group Ltd, Key Competitors 24
Tecan Group Ltd, Key Employees 25
Tecan Group Ltd, Subsidiaries 26
Why Buy From US?
What makes us stand out is that our consultants follows Robust, Refine and Result (RRR) methodology. i.e. Robust for clear definitions, approaches and sanity checking, Refine for differentiating respondents facts and opinions and Result for presenting data with story
We have set a benchmark in the industry by offering our clients with syndicated and customized market research reports featuring coverage of entire market as well as meticulous research and analyst insights.
While we don't replace traditional research, we flip the method upside down. Our dual approach of Top Bottom & Bottom Top ensures quality deliverable by not just verifying company fundamentals but also looking at the sector and macroeconomic factors.
With one step in the future, our research team constantly tries to show you the bigger picture. We help with some of the tough questions you may encounter along the way: How is the industry positioned? Best marketing channel? KPI's of competitors? By aligning every element, we help maximize success.
Our report gives you instant access to the answers and sources that other companies might choose to hide. We elaborate each steps of research methodology we have used and showcase you the sample size to earn your trust.
If you need any support, we are here! We pride ourselves on universe strength, data quality, and quick, friendly, and professional service.